Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure

This publication has 31 references indexed in Scilit:

• Biochemical detection of left-ventricular systolic dysfunction
  The Lancet, 1998
• Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril
  Cardiovascular Research, 1996
• Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.
  Heart, 1996
• Changes in plasma endothelin-1 levels reflect clinical response to β-blockade in chronic heart failure
  American Heart Journal, 1996
• Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
  Journal of the American College of Cardiology, 1996
• Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
  The American Journal of Cardiology, 1995
• Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension
  The American Journal of Cardiology, 1993
• Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance
  The American Journal of Cardiology, 1988
• Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells
  FEBS Letters, 1988
• Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
  New England Journal of Medicine, 1984